DK359986D0 - Phenylethere, fremgangsmaader til fremstilling samt farmaceutiske midler indeholdende disse - Google Patents

Phenylethere, fremgangsmaader til fremstilling samt farmaceutiske midler indeholdende disse

Info

Publication number
DK359986D0
DK359986D0 DK359986A DK359986A DK359986D0 DK 359986 D0 DK359986 D0 DK 359986D0 DK 359986 A DK359986 A DK 359986A DK 359986 A DK359986 A DK 359986A DK 359986 D0 DK359986 D0 DK 359986D0
Authority
DK
Denmark
Prior art keywords
phenylethers
procedures
manufacturing
pharmaceutical agents
agents containing
Prior art date
Application number
DK359986A
Other languages
English (en)
Other versions
DK359986A (da
DK168761B1 (da
Inventor
Brian Roy Holloway
Ralph Howe
Balbir Singh Rao
Donald Stribling
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Publication of DK359986D0 publication Critical patent/DK359986D0/da
Publication of DK359986A publication Critical patent/DK359986A/da
Application granted granted Critical
Publication of DK168761B1 publication Critical patent/DK168761B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
DK359986A 1985-07-30 1986-07-29 Phenylethere og farmaceutisk acceptable salte deraf, fremgangsmåder til fremstilling heraf samt far maceutiske midler indeholdelde disse DK168761B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8519154 1985-07-30
GB858519154A GB8519154D0 (en) 1985-07-30 1985-07-30 Aromatic ethers

Publications (3)

Publication Number Publication Date
DK359986D0 true DK359986D0 (da) 1986-07-29
DK359986A DK359986A (da) 1987-01-31
DK168761B1 DK168761B1 (da) 1994-06-06

Family

ID=10583042

Family Applications (1)

Application Number Title Priority Date Filing Date
DK359986A DK168761B1 (da) 1985-07-30 1986-07-29 Phenylethere og farmaceutisk acceptable salte deraf, fremgangsmåder til fremstilling heraf samt far maceutiske midler indeholdelde disse

Country Status (27)

Country Link
US (1) US4772631A (da)
EP (1) EP0210849B1 (da)
JP (2) JPH0651661B2 (da)
KR (1) KR870001142A (da)
CN (1) CN1014516B (da)
AR (1) AR242176A1 (da)
AT (1) ATE55980T1 (da)
AU (1) AU603987B2 (da)
CA (1) CA1283122C (da)
CS (1) CS266593B2 (da)
DD (1) DD251551A5 (da)
DE (1) DE3673722D1 (da)
DK (1) DK168761B1 (da)
ES (1) ES2002720A6 (da)
FI (1) FI88030C (da)
GB (1) GB8519154D0 (da)
GR (1) GR861994B (da)
HU (1) HUT44757A (da)
IE (1) IE60157B1 (da)
IL (1) IL79447A0 (da)
NO (1) NO170480C (da)
NZ (1) NZ217011A (da)
PH (1) PH22503A (da)
PL (1) PL152320B1 (da)
PT (1) PT83085B (da)
SU (1) SU1632370A3 (da)
ZA (1) ZA865097B (da)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0300290B1 (de) * 1987-07-21 1991-12-18 F. Hoffmann-La Roche Ag Phenoxypropanolamine
GB8801306D0 (en) * 1988-01-21 1988-02-17 Ici Plc Chemical compounds
GB8905336D0 (en) * 1989-03-08 1989-04-19 Ici Plc Chemical compounds
GB8910374D0 (en) * 1989-05-05 1989-06-21 Ici Plc Chemical compounds
KR920005952B1 (ko) * 1989-05-26 1992-07-25 이사무 이와이 오수정화조의 여과재 순환 정화장치
GB8925032D0 (en) * 1989-11-06 1989-12-28 Ici Plc Chemical compounds
GB8926083D0 (en) * 1989-11-17 1990-01-10 Ici Plc Therapeutic agents
GB9003185D0 (en) * 1990-02-13 1990-04-11 Ici Plc Pharmaceutical compositions
US5151439A (en) * 1990-05-04 1992-09-29 American Cyanamid Company Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles
US5106867A (en) * 1990-05-04 1992-04-21 American Cyanamid Company Method of increasing lean meat in edible animals
US5061727A (en) 1990-05-04 1991-10-29 American Cyanamid Company Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles
US5245053A (en) * 1990-05-04 1993-09-14 American Cyanamid Company Substituted 5-(2-(2-aryl-2-hydroxyethyl)-amino)propyl)-1,3-benzodioxoles
GB9016655D0 (en) * 1990-07-30 1990-09-12 Ici Plc Therapeutic agents
US5502078A (en) * 1991-05-28 1996-03-26 Zeneca Limited Chemical compounds
GB9111426D0 (en) * 1991-05-28 1991-07-17 Ici Plc Chemical compounds
GB9111425D0 (en) * 1991-05-28 1991-07-17 Ici Plc Chemical compounds
GB9224740D0 (en) * 1992-11-26 1993-01-13 Ici Plc Therapeutic agents
US5578638A (en) * 1993-11-05 1996-11-26 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists
US5563171A (en) * 1993-11-05 1996-10-08 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3-adrenergic agonists
US5776983A (en) * 1993-12-21 1998-07-07 Bristol-Myers Squibb Company Catecholamine surrogates useful as β3 agonists
US5488064A (en) * 1994-05-02 1996-01-30 Bristol-Myers Squibb Company Benzo 1,3 dioxole derivatives
US5491134A (en) * 1994-09-16 1996-02-13 Bristol-Myers Squibb Company Sulfonic, phosphonic or phosphiniic acid β3 agonist derivatives
US5541204A (en) * 1994-12-02 1996-07-30 Bristol-Myers Squibb Company Aryloxypropanolamine β 3 adrenergic agonists
US6075040A (en) * 1996-09-05 2000-06-13 Eli Lilly And Company Selective β3 adrenergic agonists
ZA967892B (en) * 1995-09-21 1998-03-18 Lilly Co Eli Selective β3 adrenergic agonists.
US5770615A (en) * 1996-04-04 1998-06-23 Bristol-Myers Squibb Company Catecholamine surrogates useful as β3 agonists
EP0827746B1 (en) 1996-09-05 2002-04-03 Eli Lilly And Company Carbazole analogues as selective beta3 adrenergic agonists
CO5011072A1 (es) * 1997-12-05 2001-02-28 Lilly Co Eli Etanolaminas pirazinil substituidas como agfonistas de los receptores
GB9812709D0 (en) * 1998-06-13 1998-08-12 Glaxo Group Ltd Chemical compounds
US6344481B1 (en) 1999-03-01 2002-02-05 Pfizer Inc. Thyromimetic antiobesity agents
US7504435B2 (en) * 2001-01-31 2009-03-17 The Arizona Board Of Regents On Behalf Of The University Of Arizona Method for stimulating weight loss and/or for lowering triglycerides in patients
US7709677B2 (en) * 2001-01-31 2010-05-04 Glaxosmithkline Llc Process of preparing arylethanoldiamines
GB0102407D0 (en) 2001-01-31 2001-03-14 Glaxo Group Ltd Process
US7202222B2 (en) * 2003-01-06 2007-04-10 National Bioscience Corporation Methods for treatment of obesity and effective fat loss promotion
US8399518B2 (en) * 2007-02-27 2013-03-19 University Of Arizona Office Of Technology Transfer Administration of 3,5-diiodothyropropionic acid for stimulating weight loss, and/or lowering triglyceride levels, and/or treatment of metabolic syndrome
US8476227B2 (en) 2010-01-22 2013-07-02 Ethicon Endo-Surgery, Inc. Methods of activating a melanocortin-4 receptor pathway in obese subjects
US9044606B2 (en) 2010-01-22 2015-06-02 Ethicon Endo-Surgery, Inc. Methods and devices for activating brown adipose tissue using electrical energy
US9522129B2 (en) 2010-08-03 2016-12-20 Velicept Therapeutics, Inc. Pharmaceutical Combination
US9907767B2 (en) 2010-08-03 2018-03-06 Velicept Therapeutics, Inc. Pharmaceutical compositions and the treatment of overactive bladder
WO2013130968A1 (en) * 2012-03-01 2013-09-06 University Of Cincinnati Ros-activated compounds as selective anti-cancer therapeutics
CA2969405A1 (en) 2014-12-03 2016-06-09 Velicept Therapeutics, Inc. Compositions and methods of using modified release solabegron for lower urinary tract symptoms
US10080884B2 (en) 2014-12-29 2018-09-25 Ethicon Llc Methods and devices for activating brown adipose tissue using electrical energy
US10092738B2 (en) 2014-12-29 2018-10-09 Ethicon Llc Methods and devices for inhibiting nerves when activating brown adipose tissue
EP3365321B1 (en) 2015-10-23 2023-12-13 B3AR Therapeutics, Inc. Solabegron zwitterion and uses thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES373606A1 (es) * 1968-11-18 1972-06-01 Pfizer Un procedimiento para la preparacion de nuevos derivados depropanolamina.
GB1245148A (en) * 1968-11-18 1971-09-08 Pfizer Ltd Propanolamine derivatives
SE354851B (da) * 1970-02-18 1973-03-26 Haessle Ab
US4146638A (en) * 1976-02-17 1979-03-27 Boehringer Ingelheim Gmbh N-(3-phenoxy-2-hydroxy-propyl)-n-(2-phenyl-2-hydroxy-ethyl)-amines
US4191765A (en) * 1976-05-25 1980-03-04 Hoechst Aktiengesellschaft 1-Aryloxy-2-hydroxy-3-aminopropanes
SE416545B (sv) * 1976-10-07 1981-01-19 Haessle Ab Forfarande for framstellning av nya hjertaktiva 1-frnoxi-3-aminopropan-2-ol-derivat
CH632987A5 (en) * 1976-10-07 1982-11-15 Haessle Ab Process for preparing novel amines
EP0006735B1 (en) * 1978-06-28 1983-06-15 Beecham Group Plc Secondary amines, their preparation, pharmaceutical compositions containing them and their use
SE7807408L (sv) * 1978-06-30 1979-12-31 Haessle Ab Hjertaktiva foreningar
US4338333A (en) * 1979-06-16 1982-07-06 Beecham Group Limited Ethanamine derivatives their preparation and use in pharmaceutical compositions
DE3061693D1 (en) * 1979-10-25 1983-02-24 Beecham Group Plc Secondary amines, their preparation and use in pharmaceutical compositions
IL65541A0 (en) * 1981-05-06 1982-07-30 Haessle Ab Alkylamino-2-propanols,process for their preparation and pharmaceutical preparations containing same
GB8415377D0 (en) * 1984-06-15 1984-07-18 Beecham Group Plc Compounds
GB8510146D0 (en) * 1985-04-20 1985-05-30 Smith Kline French Lab Chemical compounds & processes

Also Published As

Publication number Publication date
IL79447A0 (en) 1986-10-31
PL260759A1 (en) 1988-09-15
JPH06340597A (ja) 1994-12-13
HUT44757A (en) 1988-04-28
AU603987B2 (en) 1990-12-06
IE861827L (en) 1987-01-30
JPS6277357A (ja) 1987-04-09
AR242176A1 (es) 1993-03-31
FI862896A (fi) 1987-01-31
NO863061L (no) 1987-02-02
ES2002720A6 (es) 1988-10-01
PT83085B (pt) 1989-01-30
FI862896A0 (fi) 1986-07-09
DE3673722D1 (en) 1990-10-04
ATE55980T1 (de) 1990-09-15
US4772631A (en) 1988-09-20
NO863061D0 (no) 1986-07-29
DD251551A5 (de) 1987-11-18
SU1632370A3 (ru) 1991-02-28
CA1283122C (en) 1991-04-16
PL152320B1 (en) 1990-12-31
NZ217011A (en) 1990-02-26
GR861994B (en) 1986-11-26
JPH0651661B2 (ja) 1994-07-06
GB8519154D0 (en) 1985-09-04
KR870001142A (ko) 1987-03-11
DK359986A (da) 1987-01-31
CN1014516B (zh) 1991-10-30
CN86105400A (zh) 1987-03-11
IE60157B1 (en) 1994-06-15
CS573586A2 (en) 1989-04-14
PH22503A (en) 1988-09-12
FI88030B (fi) 1992-12-15
ZA865097B (en) 1987-03-25
EP0210849A1 (en) 1987-02-04
NO170480C (no) 1992-10-21
FI88030C (fi) 1993-03-25
NO170480B (no) 1992-07-13
AU6002986A (en) 1987-02-05
PT83085A (en) 1986-08-01
EP0210849B1 (en) 1990-08-29
DK168761B1 (da) 1994-06-06
JPH0819062B2 (ja) 1996-02-28
CS266593B2 (en) 1990-01-12

Similar Documents

Publication Publication Date Title
DK359986D0 (da) Phenylethere, fremgangsmaader til fremstilling samt farmaceutiske midler indeholdende disse
DK164868C (da) Imidazooe4,5-baaquinolin-2-on-derivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse
DK328586D0 (da) Phenylethanolaminotetraliner og fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende dem
DK158587A (da) Thiazepinforbindelser, fremgangsmaader til fremstilling deraf samt farmaceutiske, praeparater, der indeholder disse forbindelser
DK219387A (da) Aminothiazol- og aminooxazolderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse
DK164594C (da) 1,4-dihydro-pyridin-3,5-yl-dicarboxylsyrederivater, farmaceutiske praeparater indeholdende disse derivater samt fremgangsmaade til fremstilling deraf
DK165367C (da) Imidazolylalkylguanidinderivater, fremgangsmaade til fremstilling heraf samt laegemidler indeholdende disse forbindelser
DK162221C (da) Cinnolinforbindelser, fremgangsmaade til fremstilling deraf og farmaceutiske midler indeholdende forbindelserne
DK206785D0 (da) Benzazepinderivater, laegemidler indeholdende disse samt fremgangsmaade til fremstilling deraf
DK66086D0 (da) Dihydropyridiner, fremgangsmaader til fremstilling heraf samt farmaceutiske midler indeholdende disse
DK506386D0 (da) Flavonderivater, fremgangsmaader til fremstilling heraf samt farmaceutiske midler indeholdende disse
DK486789A (da) Benzoxazolinonderivater, fremgangsmaader til fremstilling deraf samt farmaceutiske midler indeholdende disse
DK165951C (da) Imidazolderivater, fremgangsmaade til fremstilling heraf samt laegemidler indeholdende disse
DK162600C (da) Oe4-(2-hydroxycyklohexylmethyl)phenylaaalkansyrederivater og fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse
DK307085A (da) 4-phenyl-2-trifluormethyl-1,3-dioxan-5-ylheptensyrederivater, fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse
DK191086D0 (da) Benzisoselenazolonylderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse
DK165885D0 (da) Peptider, fremgangsmaade til fremstilling deraf, samt farmaceutiske praeparater, indeholdende disse peptider
DK451684A (da) Quinazolinderivater, fremgangsmaade til fremstilling deraf samt laegemidler indeholdende disse forbindelser
DK65986D0 (da) Dihydropyridiner, fremgangsmaader til fremstilling heraf samt farmaceutiske midler indeholdende disse
DK160885A (da) Benzazepinderivater, fremgangsmaade til fremstilling deraf samt praeparater indeholdende disse
DK166686D0 (da) Phosphinforbindelser, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende disse forbindelser
DK501385D0 (da) 1,3,4-thiadiazolderivater, fremgangsmaade til fremstilling heraf samt laegemidler indeholdende disse forbindelser
DK65686A (da) Dihydropyridiner, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende disse
DK51785A (da) 1,4-aminoalkylamino-9h-thioxanthen-9-oner, laegemidler indeholdende disse samt fremgangsmaade til fremstilling deraf
DK379287D0 (da) 1,3-propandiaminderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed